FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Yupelri (revefenacin) - November 09, 2018
- Primatene Mist (epinephrine) - November 08, 2018
- Bryhali (halobetasol propionate) - November 06, 2018
- Dsuvia (sufentanil) - November 02, 2018
- Lorbrena (lorlatinib) - November 02, 2018
- Udenyca (pegfilgrastim-cbqv) - November 02, 2018
- Sympazan (clobazam) - November 01, 2018
- Hyrimoz (adalimumab-adaz) - October 30, 2018
- Bijuva (estradiol and progesterone) - October 28, 2018
- Xofluza (baloxavir marboxil) - October 24, 2018
- Khapzory (levoleucovorin) - October 19, 2018
- Talzenna (talazoparib) - October 16, 2018
- Yutiq (fluocinolone acetonide) - October 12, 2018
- Revcovi (elapegademase-lvlr) - October 05, 2018
- Tegsedi (inotersen) - October 05, 2018
- Nuzyra (omadacycline) - October 02, 2018
- Seysara (sarecycline) - October 01, 2018
- Arikayce (amikacin liposome) - September 28, 2018
- Libtayo (cemiplimab-rwlc) - September 28, 2018
- Xyosted (testosterone enanthate) - September 28, 2018
